HCV layoffs announced this Friday

[anonymous]

Any truth to this?

 

[anonymous]

Any truth to this?

NO not even close Try again (and again and again) Word I heard was two
scenarios,Mid December this year or March next year HCV ONLY 30% First Round


HR

 

[anonymous]

NO not even close Try again (and again and again) Word I heard was two
scenarios,Mid December this year or March next year HCV ONLY 30% First Round


HR

What about HIV?

 

[anonymous]

Any truth to this?

The word I'm getting is mid-October at the latest.

 

[anonymous]

Hold-up, maybe new guy from JP Morgan will save us? Merge us? Sell us? Why else is he here? Obviously to make a move...

A merge with BMS, or European giant? Hopefully not Sanofi, but Roche has always wanted to be back in HCV. Janssen is also an option. Companies with HCV and oncology aspirations, my bet Roche.

 

[anonymous]

That (Pfizer) is also an option. But the benefit is with EU company. To be sure something is going on. A guy doesn't leave such a big job to come to the Midwest and report to CEO unless he's going to be new CEO, or he'll do what he does best...a merger, to save AbbVie shareholders and RG's legacy. RG does not want to be labelled the high school graduate who tanked Abbvie. The question is when? Guessing something will be announced q4, but I am only guessing. Take it for what it is.

 

[anonymous]

Layoffs must occur before national meeting. Otherwise, before end of fourth quarter. Mid-November is good. Just before the holidays kick in. Yay!!!

 

[anonymous]

Q4--RG graduates DeVry Academy w. DOUBLE MAJOR. Legacy assured!

 

[anonymous]

Hold-up, maybe new guy from JP Morgan will save us? Merge us? Sell us? Why else is he here? Obviously to make a move...

A merge with BMS, or European giant? Hopefully not Sanofi, but Roche has always wanted to be back in HCV. Janssen is also an option. Companies with HCV and oncology aspirations, my bet Roche.

Former Roche/Genentech here, it is highly unlikely that they want back into a market that they once owned but would now only be a bit player, not their focus. Why would they want to take on Humira as it heads toward generic challenges? I'd see a better fit with BMS, they are fine with products that were once best in class or mediocre at best. Then again, gilead could buy just about anyone right now.

 

[anonymous]

"MASSSSS LAYOFFINGS?? JA JA JA!!" LootsieLouLouie says, buttering his schnitzel in anticipation for the carnage.

 

[anonymous]

Former Roche/Genentech here, it is highly unlikely that they want back into a market that they once owned but would now only be a bit player, not their focus. Why would they want to take on Humira as it heads toward generic challenges? I'd see a better fit with BMS, they are fine with products that were once best in class or mediocre at best. Then again, gilead could buy just about anyone right now.

 

[anonymous]

You must be an analyst making 7 figures. Your assessment is so erudite.

 

[anonymous]

It ain't over till its over!

 

[anonymous]

If you see a fork in the road, take it.

 

[anonymous]

Always go to other people's funerals, otherwise they won't come to yours!

 

[anonymous]

Always go to other people's funerals, otherwise they won't come to yours!

A Nickel ain't worth a dime anymore!

It's Friday, crickets...

 

[anonymous]

A Nickel ain't worth a dime anymore!

It's Friday, crickets...

Gee Whiz ,Yawn ,just saying Folks